| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC4195 | Plx647(ome) | Slightly less potent inhibitor of FMS than PLX647 but has better aqueous solubility |
|
| DCC4196 | Pm00104 | Potent anticancer tetrahydroisoquinoline alkaloid, being able to form a covalent bond with the amino group of a guanine in selected triplets of DNA duplexes and eventually give rise to double-strand breaks |
|
| DCC4197 | Pmed-1 | Novel inhibitor of β-catenin signaling, significantly reduced β-catenin activity in hepatoblastoma and several HCC cells |
|
| DCC4198 | Pmmb-317 | Novel potent irriversible dual inhibitor of tubulin and epidermal growth factor receptor (EGFR), inducing the apoptosis of A549 cells in a dose- and time-dependent manner, along with decrease in mitochondrial membrane potential (MMP), production of ROS an |
|
| DCC4199 | Pmpmease-in L-23 | Novel inhibitor of prenylated methylated protein methyl esterase (PMPMEase), a key enzyme in the reversible methylation/demethylation step in the protein prenylation pathway |
|
| DCC4200 | Pmpmease-in L-28 | Novel inhibitor of prenylated methylated protein methyl esterase (PMPMEase), a key enzyme in the reversible methylation/demethylation step in the protein prenylation pathway |
|
| DCC4201 | P-mppf Dihydrochloride | Selective 5-HT1A serotonin receptor antagonist |
|
| DCC4202 | P-nitro-pifithrin-α | Cell-permeable analog of pifithrin-α, potently blocking p53-mediated expression of p21/WAF1 and apoptosis |
|
| DCC4203 | Pnr-4-20 | Novel G Protein-Biased Cannabinoid 1 (CB1) Receptor Agonist |
|
| DCC4204 | Pnu-292137 | Potent inhibitor of CDK2/cyclin A |
|
| DCC4205 | Pnu-69176e | Allosteric modulator of 5-HT(2C)R with no intrinsic agonist activity |
|
| DCC4206 | Pnz-tmp | The first small-molecule approach capable of detecting and controlling engineered cell-cell outputs |
|
| DCC4207 | Podoverine A | Novel microtubule destabilizing natural product from the Podophyllum species |
|
| DCC4208 | Pol I Inhibitor T5 | Novel RNA polymerase I inhibitor, targeting ribosomal DNA G-quadruplexes, potently and selectively inhibiting cell growth by high-affinity binding to G4s in ribosomal DNA, impairing RNA polymerase I (Pol I) elongation, inducing a rapid inhibition of Pol I |
|
| DCC4209 | Pol7001 | Novel macrocycle antibiotic with selective and potent activity against P. aeruginosa |
|
| DCC4210 | Poloppin-ii | Novel modulator of protein-protein interactions of the mitotic polo-like kinases, targeting KRAS mutant xenografts, indicate avenues, acting synergistically with Crizotinib, an inhibitor of the c-MET receptor, against mutant KRAS-expressing cancer cells |
|
| DCC4211 | Poloxipan | Pan-Specific Inhibitor of the Polo-Box Domains of Polo-like Kinases Arrests Cancer Cells in Mitosis |
|
| DCC4212 | Poly(ethyleneimine) Solution | Used for the transfection of a broad variety of cell lines; Antimicrobial; Novel binding agent of diffusive gradients in thin-films (DGT) technique (PEI-DGT) |
|
| DCC4213 | polygonatone D | Novel activator of Adenosine monophosphate (AMP)-activated protein kinase (AMPK) |
|
| DCC4214 | Polymyxin | Antibiotic as a last-line therapy to treat infections caused by these life-threatening 'superbugs' |
|
| DCC4215 | polyphenol 13b | Novel pan-inhibitor of KCa3.1/KCa2 channels |
|
| DCC4216 | Pom2-c-hmbp | Potent Activator of Vγ9Vδ2 T-Lymphocytes; HMBPP ananlog prodrug |
|
| DCC4217 | Ponfibrate | Hypobetalipoproteinemic and Lipid decreasing agent |
|
| DCC4218 | Poziotinib Hydrochloride | Novel pan-human EGF receptor (HER) inhibitor |
|
| DCC4219 | Ppa250 | Novel iNOS homodimerization inhibitor |
|
| DCC4220 | Pparalpha/delta-in-11 | The first reported PPARα/δ dual antagonist |
|
| DCC4221 | Pparalpha/gamma Agonist N15 | Novel dual PPARα/γ agonist, ameliorating insulin resistance and gluconeogenesis in vivo and vitro |
|
| DCC4222 | Ppi Inhibitor-i | Novel inhibitor of protein-protein interaction (PPI), blocking #212121; font-family: BlinkMacSystemFont, -apple-system, "Segoe UI", Roboto, Oxygen, Ubuntu, Cantarell, "Fira Sans", "Droid Sans", "Helvetica Neue", sans-serif; font-size: 14px; font-style: no |
|
| DCC4223 | pp-ii-a03 | Novel insulin mimetic |
|
| DCC4224 | Ppi-in-3344 | Novel pan-RAS-effector PPI inhibitor |
|
